27 A Multistress Model for High Throughput Screening Against
Nonreplicating Mycobacterium tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 611
Ben Gold, Thulasi Warrier, and Carl Nathan
28 Antimicrobial Susceptibility Testing for Mycobacterium sps
in High-Throughput Format . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 637
Esther Pe ´rez-Herra ´ n and Alfonso Mendoza
29 High-Content Analysis Monitoring Intracellular Trafficking
and Replication of Mycobacterium tuberculosis Inside Host Cells . . . . . . . . . . . . . . 649
Nathalie Deboosere, Ime `ne Belhaouane, Arnaud Machelart,
Eik Hoffmann, Alexandre Vandeputte, and Priscille Brodin
30 Efficient Measurement of Drug Interactions with DiaMOND
(Diagonal Measurement of N-Way Drug Interactions) . . . . . . . . . . . . . . . . . . . . . . 703
Nhi Van, Yonatan N. Degefu, and Bree B. Aldridge
31 Drug Sensitivity Testing of Mycobacterium tuberculosis Growing
in a Hollow Fiber Bioreactor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715
A. Brett Mason and Ve ´ronique Dartois
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 733
Contents
ix